OMED

OncoMed Pharmaceuticals, Inc.

OMED

Delisted

OMED was delisted on the 22nd of April, 2019.

42 hedge funds and large institutions have $13.1M invested in OncoMed Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 16 closing their positions.

2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3

Holders

Holders Change

-12

Holders Change %

-22.22%

% of All Funds

0.94%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

1	HP 1 Harbourvest Partners Boston, Massachusetts	$1.42M
2	2 Renaissance Technologies New York	$911K
3	3 Jacobs Levy Equity Management Florham Park, New Jersey	$120K
4	BC 4 Birchview Capital Burlington, Vermont	$129K
5	5 Deutsche Bank Frankfurt Am Main Ge, Germany	$40K

Top Sellers

1	NC 1 Nexthera Capital New York	$0
2	SI 2 Sofinnova Investments Menlo Park, California	$0
3	PA 3 Perceptive Advisors New York	$1.28M
4	4 Vanguard Group Malvern, Pennsylvania	$266K
5	ECM 5 Endurant Capital Management San Mateo, California	$0

#	Name	Market Value	Shares	Shares Change	Shares Change %
1	1 Primecap Management Pasadena, California	$4.12M	5,506,300	-192,400	-3%
2	BI 2 BVF Inc San Francisco, California	$3.02M	4,042,989	–	–
3	HP 3 Harbourvest Partners Boston, Massachusetts	$1.42M	1,901,106	+1,901,106	New
4	PA 4 Perceptive Advisors New York	$1.28M	1,719,111	-901,786	-34%
5	5 Renaissance Technologies New York	$911K	1,218,607	+401,207	+49%
6	CS 6 Candriam SCA Strassen, Luxembourg, Luxembourg	$284K	380,000	–	–
7	7 Vanguard Group Malvern, Pennsylvania	$266K	355,294	-656,062	-65%
8	CC 8 Cannell & Co New York	$226K	303,071	–	–
9	9 BlackRock New York	$169K	227,637	-13,566	-6%
10	10 Acadian Asset Management Boston, Massachusetts	$146K	195,107	+40,353	+26%
11	11 Norges Bank Oslo, Norway	$136K	182,357	–	–
12	12 Geode Capital Management Boston, Massachusetts	$129K	173,563	+46,083	+36%
13	BC 13 Birchview Capital Burlington, Vermont	$129K	172,557	+53,868	+45%
14	14 Jacobs Levy Equity Management Florham Park, New Jersey	$120K	160,244	+75,514	+89%
15	15 D.E. Shaw & Co New York	$117K	156,249	-171,920	-52%
16	BCM 16 Bridgeway Capital Management Houston, Texas	$98K	130,900	–	–
17	SIM 17 Spark Investment Management New York	$68K	91,400	-4,300	-4%
18	18 Dimensional Fund Advisors Austin, Texas	$64K	85,741	-8,500	-9%
19	19 Bank of America Charlotte, North Carolina	$63K	83,826	–	–
20	20 Northern Trust Chicago, Illinois	$44K	58,048	-1,400	-2%
21	PAM 21 Panagora Asset Management Boston, Massachusetts	$41K	54,503	+29,205	+115%
22	22 Deutsche Bank Frankfurt Am Main Ge, Germany	$40K	54,700	+54,700	New
23	NSEDCP 23 NJ State Employees Deferred Compensation Plan Trenton, New Jersey	$28K	38,000	–	–
24	24 Tudor Investment Corp Stamford, Connecticut	$24K	31,909	–	–
25	25 Macquarie Group Sydney, NSW 2000, Australia	$22K	29,589	-21,720	-42%

OncoMed Pharmaceuticals, Inc. OMED

Top Buyers

Top Sellers

OncoMed Pharmaceuticals, Inc.

OMED